| Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer D Zhang, Q Hu, X Liu, Y Ji, HP Chao, Y Liu, A Tracz, J Kirk, S Buonamici, ... Nature communications 11 (1), 1-19, 2020 | 104 | 2020 |
| Tumor dormancy and slow-cycling cancer cells JE Davis, J Kirk, Y Ji, DG Tang Human Cell Transformation, 199-206, 2019 | 51 | 2019 |
| LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer Q Li, B Liu, HP Chao, Y Ji, Y Lu, R Mehmood, C Jeter, T Chen, JR Moore, ... Nature communications 10 (1), 1-19, 2019 | 21 | 2019 |
| LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor Y Ji, R Kumar, A Ghokale, HP Chao, K Rycaj, X Chen, Q Li, DG Tang Seminars in Cancer Biology, 2021 | 15 | 2021 |
| Evidence for context-dependent functions of KDM5B in prostate development and prostate cancer B Liu, R Kumar, HP Chao, R Mehmood, Y Ji, A Tracz, DG Tang Oncotarget 11 (46), 4243, 2020 | 13 | 2020 |
| Dysregulated Alternative Splicing Landscape Identifies Intron Retention as a Hallmark and Spliceosome as a Therapeutic Vulnerability in Aggressive Prostate Cancer D Zhang, Q Hu, Y Ji, HP Chao, A Tracz, J Kirk, S Buonamici, P Zhu, ... bioRxiv, 634402, 2019 | 2 | 2019 |
| Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer Q Li, B Liu, HP Chao, Y Ji, Y Lu, R Mehmood, C Jeter, T Chen, JR Moore, ... Nature communications 11 (1), 1-1, 2020 | | 2020 |
| LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer (vol 10, 5494, 2019) Q Li, B Liu, HP Chao, Y Ji, Y Lu, R Mehmood, C Jeter, T Chen, JR Moore, ... NATURE COMMUNICATIONS 11 (1), 2020 | | 2020 |
